|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA
2 Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, CT, USA
3 Division of Molecular Physiology, Faculty of Life Sciences, University of Dundee, Dundee, United Kingdom
* To whom correspondence should be addressed. E-mail: lawrence.young{at}yale.edu.
AMP-activated protein kinase (AMPK) is emerging as a key signaling pathway which modulates cellular metabolic processes. In skeletal muscle, AMPK is activated during exercise. Increased myocardial substrate metabolism during exercise could be explained by AMPK activation. Although AMPK is known to be activated during myocardial ischemia, it remains uncertain whether AMPK is activated in response to the physiologic increases in cardiac work associated with exercise. Therefore, we evaluated cardiac AMPK activity in rats at rest and following 10 minutes of treadmill running at moderate (15% grade, 16m/min) or high intensity (15% grade, 32m/min). Total AMPK activity in the heart increased in proportion to exercise intensity (P<0.05). AMPK activity associated with the
2 catalytic subunit increased 2.8±0.4-fold (p<0.02 vs. rest) and 4.5±0.6-fold (p<0.001 vs. rest) with moderate and high intensity exercise, respectively. AMPK activity associated with the
1 subunit increased to a lesser extent. Phosphorylation of the Thr172 regulatory site on AMPK
catalytic subunits increased during exercise (p<0.001). There was no increase in Akt phosphorylation during exercise. The changes in AMPK activity during exercise were associated with physiologic AMPK effects: GLUT4 glucose transporter translocation to the sarcolemma and acetyl-CoA carboxylase phosphorylation. Thus, cardiac AMPK activity increases progressively with exercise intensity, supporting the hypothesis that AMPK has a physiologic role in the heart.
This article has been cited by other articles:
![]() |
K.-O. Stenslokken, S. Ellefsen, J. A. W. Stecyk, M. B. Dahl, G. E. Nilsson, and J. Vaage Differential regulation of AMP-activated kinase and AKT kinase in response to oxygen availability in crucian carp (Carassius carassius) Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2008; 295(6): R1803 - R1814. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Dobrzyn, H. Sampath, A. Dobrzyn, M. Miyazaki, and J. M. Ntambi Loss of stearoyl-CoA desaturase 1 inhibits fatty acid oxidation and increases glucose utilization in the heart Am J Physiol Endocrinol Metab, February 1, 2008; 294(2): E357 - E364. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zhou, H. Huang, C. L. Yuan, W. Keung, G. D. Lopaschuk, and W. C. Stanley Metabolic response to an acute jump in cardiac workload: effects on malonyl-CoA, mechanical efficiency, and fatty acid oxidation Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H954 - H960. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Miller, J. Li, K. M. Sinusas, G. D. Holman, and L. H. Young Infusion of a biotinylated bis-glucose photolabel: a new method to quantify cell surface GLUT4 in the intact mouse heart Am J Physiol Endocrinol Metab, June 1, 2007; 292(6): E1922 - E1928. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Arad, C. E. Seidman, and J.G. Seidman AMP-Activated Protein Kinase in the Heart: Role During Health and Disease Circ. Res., March 2, 2007; 100(4): 474 - 488. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Athea, B. Viollet, P. Mateo, D. Rousseau, M. Novotova, A. Garnier, S. Vaulont, J. R. Wilding, A. Grynberg, V. Veksler, et al. AMP-Activated Protein Kinase {alpha}2 Deficiency Affects Cardiac Cardiolipin Homeostasis and Mitochondrial Function Diabetes, March 1, 2007; 56(3): 786 - 794. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. Allard, H. L. Parsons, R. Saeedi, R. B. Wambolt, and R. Brownsey AMPK and metabolic adaptation by the heart to pressure overload Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H140 - H148. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. W. Dolinsky and J. R. B. Dyck Role of AMP-activated protein kinase in healthy and diseased hearts Am J Physiol Heart Circ Physiol, December 1, 2006; 291(6): H2557 - H2569. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Li, D. L. Coven, E. J. Miller, X. Hu, M. E. Young, D. Carling, A. J. Sinusas, and L. H. Young Activation of AMPK {alpha}- and {gamma}-isoform complexes in the intact ischemic rat heart Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1927 - H1934. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. B. Dyck and G. D. Lopaschuk AMPK alterations in cardiac physiology and pathology: enemy or ally? J. Physiol., July 1, 2006; 574(1): 95 - 112. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nickerson, G. F. Elphick, J. Campisi, B. N. Greenwood, and M. Fleshner Physical activity alters the brain Hsp72 and IL-1{beta} responses to peripheral E. coli challenge Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2005; 289(6): R1665 - R1674. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Li, E. J. Miller, J. Ninomiya-Tsuji, R. R. Russell III, and L. H. Young AMP-Activated Protein Kinase Activates p38 Mitogen-Activated Protein Kinase by Increasing Recruitment of p38 MAPK to TAB1 in the Ischemic Heart Circ. Res., October 28, 2005; 97(9): 872 - 879. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. C. Stanley, F. A. Recchia, and G. D. Lopaschuk Myocardial Substrate Metabolism in the Normal and Failing Heart Physiol Rev, July 1, 2005; 85(3): 1093 - 1129. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. An, G. Kewalramani, D. Qi, T. Pulinilkunnil, S. Ghosh, A. Abrahani, R. Wambolt, M. Allard, S. M. Innis, and B. Rodrigues {beta}-Agonist stimulation produces changes in cardiac AMPK and coronary lumen LPL only during increased workload Am J Physiol Endocrinol Metab, June 1, 2005; 288(6): E1120 - E1127. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Baron, J. Li, R. R. Russell III, D. Neumann, E. J. Miller, R. Tuerk, T. Wallimann, R. L. Hurley, L. A. Witters, and L. H. Young Dual Mechanisms Regulating AMPK Kinase Action in the Ischemic Heart Circ. Res., February 18, 2005; 96(3): 337 - 345. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Yang and G. D. Holman Insulin and Contraction Stimulate Exocytosis, but Increased AMP-activated Protein Kinase Activity Resulting from Oxidative Metabolism Stress Slows Endocytosis of GLUT4 in Cardiomyocytes J. Biol. Chem., February 11, 2005; 280(6): 4070 - 4078. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Li, X. Hu, P. Selvakumar, R. R. Russell III, S. W. Cushman, G. D. Holman, and L. H. Young Role of the nitric oxide pathway in AMPK-mediated glucose uptake and GLUT4 translocation in heart muscle Am J Physiol Endocrinol Metab, November 1, 2004; 287(5): E834 - E841. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Gonzalez, R. Kumar, J. D. Mulligan, A. J. Davis, R. Weindruch, and K. W. Saupe Metabolic adaptations to fasting and chronic caloric restriction in heart, muscle, and liver do not include changes in AMPK activity Am J Physiol Endocrinol Metab, November 1, 2004; 287(5): E1032 - E1037. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Gonzalez, R. Kumar, J. D. Mulligan, A. J. Davis, and K. W. Saupe Effects of aging on cardiac and skeletal muscle AMPK activity: basal activity, allosteric activation, and response to in vivo hypoxemia in mice Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2004; 287(5): R1270 - R1275. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Czubryt and E. N. Olson Balancing Contractility and Energy Production: The Role of Myocyte Enhancer Factor 2 (MEF2) in Cardiac Hypertrophy Recent Prog. Horm. Res., January 1, 2004; 59(1): 105 - 124. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |